BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4348395)

  • 1. Cell-bound antiglial immunity in patients with malignant tumors of the brain.
    Wahlström T; Saksela E; Troupp H
    Cell Immunol; 1973 Feb; 6(2):161-70. PubMed ID: 4348395
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro demonstration of cell-mediated immunity to human brain tumors.
    Levy NL; Mahaley MS; Day ED
    Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
    Levy NL
    J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
    [No Abstract]   [Full Text] [Related]  

  • 4. Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient.
    Hitchcock MH; Hollinshead AC; Chretien P; Rizzoli HV
    Cancer; 1977 Aug; 40(2):660-6. PubMed ID: 196738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface antigen(s) common to human astrocytoma cells.
    Coakham H
    Nature; 1974 Jul; 250(464):328-30. PubMed ID: 4859513
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific cellular immune responses in patients with malignant gliomas.
    Sheikh KM; Apuzzo ML; Weiss MH
    Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common antigen in meningioma-derived cell cultures.
    Catalano LW; Harter DH; Hsu KC
    Science; 1972 Jan; 175(4018):180-2. PubMed ID: 4332758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses in patients with gliomas.
    Brooks WH; Caldwell HD; Mortara RH
    Surg Neurol; 1974 Nov; 2(6):419-23. PubMed ID: 4372736
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test.
    Miggiano VC; Bernoco D; Lightbody J; Trinchieri G; Ceppellini R
    Transplant Proc; 1972 Jun; 4(2):231-7. PubMed ID: 5034149
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative cell-mediated immune status of patients with malignant glial tumors.
    Sheikh KM; Apuzzo ML; Weiss MH
    Neurol Res; 1979; 1(2):133-45. PubMed ID: 233266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
    Brooks WH; Netsky MG; Normansell DE; Horwitz DA
    J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Immunological investigations on human brain tumor patients.
    Mahaley MS
    Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the immunological status of patients with cerebral neoplasms].
    Perria C; Di Benedetto G; Barabino A; Soldà AM; Indiveri F
    Boll Soc Ital Biol Sper; 1974 Nov; 50(22):1930-5. PubMed ID: 4376965
    [No Abstract]   [Full Text] [Related]  

  • 15. [Delayed hypersensitivity reactions in patients bearing malignant brain tumors with human tumor cell lines grown in vitro].
    Febvre H; Maunoury R; Constans JP; Trouillas P
    Int J Cancer; 1972 Jul; 10(1):221-32. PubMed ID: 4350512
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro methods in cell-mediated immunity: a progress report.
    Cell Immunol; 1973 Mar; 6(3):331-47. PubMed ID: 4540243
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas.
    Eggers AE
    Neurology; 1972 Mar; 22(3):246-50. PubMed ID: 4334554
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system.
    Kumar S; Taylor G; Steward JK; Waghe MA; Morris-Jones P
    Int J Cancer; 1973 Jul; 12(1):194-205. PubMed ID: 4364270
    [No Abstract]   [Full Text] [Related]  

  • 19. Human intracranial tumors: effect of autologous serum addition on leucocyte migration inhibition.
    Böker DK
    Acta Neurochir (Wien); 1982; 65(3-4):227-37. PubMed ID: 7180599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-mediated immunological non-reactivity between histoincompatible cells in tetraparental mice.
    Phillips SM; Martin WJ; Shaw AR; Wegmann TG
    Nature; 1971 Nov; 234(5325):146-8. PubMed ID: 4942675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.